The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.
Open accessAbstract
We describe here a new method for predicting class II major histocompatibility complex-binding peptides, based on the preferences observed in a systematic series of peptide binding experiments where each position in a "minimal" peptide was replaced individually by every amino acid. The DRB1*0401 peptide binding preferences were determined and incorporated into a computer program that looks through sequences for potential epitopes and assigns each a score. These scores correlate well with previously determined T cell epitopes of foreign antigens and endogenous peptides from self proteins. Our findings hold implications for the design of subunit vaccines and in the identification of autoantigenic peptide regions within self proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., & Wiley, D. C. (1993) · Nature · doi:10.1038/364033a0 · Cited by 2,379
Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., & Wiley, D. C. (1994) · Nature · doi:10.1038/368215a0 · Cited by 1,555
Germain, R. N. (1994) · Cell · doi:10.1016/0092-8674(94)90336-0 · Cited by 1,434
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A., Lane, W. S., & Strominger, J. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.27 · Cited by 887
A Molecular Basis for MHC Class II—Associated Autoimmunity
Todd, J. A., Acha-Orbea, H., Bell, J. I., Chao, N., Fronek, Z., Jacob, C. O., McDermott, M., Sinha, A. A., Timmerman, L., Steinman, L., et al. (1988) · Science · doi:10.1126/science.3368786 · Cited by 705
A sequence pattern common to T cell epitopes.
Rothbard, J. B., & Taylor, W. R. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02787.x · Cited by 601
MHC Class-II Molecules and Autoimmunity
Nepom, G. T., & Erlich, H. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.002425 · Cited by 519
Prediction of immunodominant helper T cell antigenic sites from the primary sequence.
Margalit, H., Spouge, J. L., Cornette, J. L., Cease, K. B., Delisi, C., & Berzofsky, J. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.7.2213 · Cited by 474
Promiscuous and allele-specific anchors in HLA-DR-binding peptides
Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B., & Sinigaglia, F. (1993) · Cell · doi:10.1016/0092-8674(93)90306-b · Cited by 376
Self-citationSette, A., Buus, S., Appella, E., Smith, J. A., Chesnut, R., Miles, C., Colon, S. M., & Grey, H. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3296 · Cited by 310
Cited by
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
MHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
Wang, P., Sidney, J., Dow, C., Mothé, B., Sette, A., & Peters, B. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000048 · Cited by 844
Sturniolo, T., Bono, E., Ding, J., Raddrizzani, L., Tuereci, O., Sahin, U., Braxenthaler, M., Gallazzi, F., Protti, M. P., Sinigaglia, F., et al. (1999) · Nature Biotechnology · doi:10.1038/9858 · Cited by 743
Self-citationHill, J. A., Southwood, S., Sette, A., Jevnikar, A. M., Bell, D. A., & Cairns, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.538 · Cited by 713
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
Knutson, K. L., & Disis, M. L. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0653-2 · Cited by 682
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
Southwood, S., Sidney, J., Kondo, A., del Guercio, M.-F., Appella, E., Hoffman, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., & Sette, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3363 · Cited by 665
Tumor neoantigens: building a framework for personalized cancer immunotherapy
Gubin, M. M., Artyomov, M. N., Mardis, E. R., & Schreiber, R. D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80008 · Cited by 613
Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis
Gross, D. M., Forsthuber, T., Tary-Lehmann, M., Etling, C., Ito, K., Nagy, Z. A., Field, J. A., Steere, A. C., & Huber, B. T. (1998) · Science · doi:10.1126/science.281.5377.703 · Cited by 517
Self-citationGermain, R. N., & Stefanová, I. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.467 · Cited by 436
T-cell epitope vaccine design by immunoinformatics
Patronov, A., & Doytchinova, I. (2013) · Open Biology · doi:10.1098/rsob.120139 · Cited by 426
Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?
Benoist, C., & Mathis, D. (2001) · Nature Immunology · doi:10.1038/ni0901-797 · Cited by 390
Reche, P., Glutting, J.-P., Zhang, H., & Reinherz, E. (2004) · Immunogenetics · doi:10.1007/s00251-004-0709-7 · Cited by 386
Prediction of MHC class I binding peptides using profile motifs
Reche, P. A., Glutting, J.-P., & Reinherz, E. L. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00432-9 · Cited by 375
Chemistry of peptides associated with MHC class I and class II molecules
Rammensee, H.-G. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80033-6 · Cited by 365
Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.
Hammer, J., Gallazzi, F., Bono, E., Karr, R. W., Guenot, J., Valsasnini, P., Nagy, Z. A., & Sinigaglia, F. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1847 · Cited by 307
Self-citationSmith, K. J., Pyrdol, J., Gauthier, L., Wiley, D. C., & Wucherpfennig, K. W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1511 · Cited by 294
Definition of supertypes for HLA molecules using clustering of specificity matrices
Lund, O., Nielsen, M., Kesmir, C., Petersen, A. G., R�der, G., Justesen, S., Lundegaard, C., Worning, P., Sylvester-Hvid, C., Lamberth, K., et al. (2004) · Immunogenetics · doi:10.1007/s00251-004-0647-4 · Cited by 292
Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach
Nielsen, M., Lundegaard, C., Worning, P., Hvid, C. S., Lamberth, K., Buus, S., Brunak, S., & Lund, O. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth100 · Cited by 278
Hill, J. A., Bell, D. A., Brintnell, W., Yue, D., Wehrli, B., Jevnikar, A. M., Lee, D. M., Hueber, W., Robinson, W. H., & Cairns, E. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072051 · Cited by 275
Bui, H.-H., Sidney, J., Peters, B., Sathiamurthy, M., Sinichi, A., Purton, K.-A., Mothé, B. R., Chisari, F. V., Watkins, D. I., & Sette, A. (2005) · Immunogenetics · doi:10.1007/s00251-005-0798-y · Cited by 263
Two complementary methods for predicting peptides binding major histocompatibility complex molecules
Gulukota, K., Sidney, J., Sette, A., & DeLisi, C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0937 · Cited by 259
Hervé, M., Maillére, B., Mourier, G., Texier, C., Leroy, S., & Ménez, A. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00004-7 · Cited by 48
A retro‐inverso analog mimicks the cognate peptide epitope of a CD4+ T cell clone
Bartnes, K., Hannestad, K., Guichard, G., & Briand, J. P. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270614 · Cited by 24
PANDORA v2.0: Benchmarking peptide-MHC II models and software improvements
Parizi, F. M., Marzella, D. F., Ramakrishnan, G., ‘t Hoen, P. A. C., Karimi-Jafari, M. H., & Xue, L. C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285899 · Cited by 14
Chemical Strategy and AI-Enabled Peptide Vaccine Development
Wang, X.-X., Su, J.-Y., & Li, Y.-M. (2026) · JACS Au · doi:10.1021/jacsau.6c00008 · Cited by 5
Metadata
- Authors
- Hammer, J., Bono, E., Gallazzi, F., Belunis, C., Nagy, Z., & Sinigaglia, F.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-12-01
- Volume
- 180
- Issue
- 6
- Pages
- 2353-2358
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2021002908
- Cited by
- 290
- References
- 18
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.